Balugtod, Larryven .
HRN: 21-87-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2022
CEFTRIAXONE 1G (VIAL)
09/04/2022
09/10/2022
IVT
2g
OD
Leptospirosis Severe
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes